InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 325.70
+2.10 (0.65%)
Jan 1, 2026, 5:26 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 178.1 million as of December 31, 2025. Its market cap has decreased by -23.86% in one year.
Market Cap
178.10M
Enterprise Value
306.95M
Revenue
243.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
325.70
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 178.10M, an increase of 2,678.98%. That is a compound annual growth rate of 24.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 176.95M | -34.89% |
| Dec 31, 2024 | 271.76M | 28.77% |
| Dec 31, 2023 | 211.05M | -61.66% |
| Dec 29, 2022 | 550.52M | -40.95% |
| Dec 30, 2021 | 932.28M | 111.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 114.39B |
| Danel (Adir Yeoshua) | 2.79B |
| Kamada | 1.30B |
| BrainsWay | 1.19B |
| Bait Bakfar | 991.66M |
| SofWave Medical | 981.37M |
| Ilex Medical | 745.80M |
| Novolog (Pharm-Up 1966) | 655.96M |